4-[4-[(2R)-2-hydroxy-3-(4-methylphenoxy)propyl]piperazin-1-yl]sulfonyl-1-methylpyrrole-2-carboxamide
C20H28N4O5S — CID 25487386
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-[(2R)-2-hydroxy-3-(4-methylphenoxy)propyl]piperazin-1-yl]sulfonyl-1-methylpyrrole-2-carboxamide
4-[4-[(2R)-2-hydroxy-3-(4-methylphenoxy)propyl]piperazin-1-yl]sulfonyl-1-methylpyrrole-2-carboxamide (PubChem CID 25487386) has the molecular formula C20H28N4O5S and a molecular weight of 436.53 g/mol. Its IUPAC name is 4-[4-[(2R)-2-hydroxy-3-(4-methylphenoxy)propyl]piperazin-1-yl]sulfonyl-1-methylpyrrole-2-carboxamide.
Molecular Properties
| Compound Name | 4-[4-[(2R)-2-hydroxy-3-(4-methylphenoxy)propyl]piperazin-1-yl]sulfonyl-1-methylpyrrole-2-carboxamide |
|---|---|
| PubChem CID | 25487386 |
| Molecular Formula | C20H28N4O5S |
| Molecular Weight | 436.53 g/mol |
| Exact Mass | 436.18 |
| IUPAC Name | 4-[4-[(2R)-2-hydroxy-3-(4-methylphenoxy)propyl]piperazin-1-yl]sulfonyl-1-methylpyrrole-2-carboxamide |
| SMILES | Cc1ccc(OC[C@H](O)CN2CCN(S(=O)(=O)c3cc(C(N)=O)n(C)c3)CC2)cc1 |
| InChI | InChI=1S/C20H28N4O5S/c1-15-3-5-17(6-4-15)29-14-16(25)12-23-7-9-24(10-8-23)30(27,28)18-11-19(20(21)26)22(2)13-18/h3-6,11,13,16,25H,7-10,12,14H2,1-2H3,(H2,21,26)/t16-/m1/s1 |
| InChIKey | OEZRMYMMUIYNHB-MRXNPFEDSA-N |
| XLogP | 0.18 |
| TPSA | 118.10 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.53 |
| LogP ≤ 5 | 0.18 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 25487386 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.